---
title: "West Pharmaceutical Services Inc. Stock Underperforms Tuesday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288479587.md"
description: "West Pharmaceutical Services (WST) shares fell 1.31% to $312.17 on Tuesday, underperforming the broader market and key competitors like Abbott Laboratories and Baxter International. This marks the second consecutive day of losses for WST, which remains 5.65% below its 52-week high. Trading volume was notably lower than the 50-day average."
datetime: "2026-06-02T21:04:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288479587.md)
  - [en](https://longbridge.com/en/news/288479587.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288479587.md)
---

# West Pharmaceutical Services Inc. Stock Underperforms Tuesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of West Pharmaceutical Services Inc. (WST) slid 1.31% to $312.17 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.13% to 7,609.78 and the Dow Jones Industrial Average rising 0.45% to 51,307.79.

This was the stock's second consecutive day of losses.

West Pharmaceutical Services Inc. closed 5.65% short of its 52-week high of $330.88, which the company reached on May 11th.

The stock underperformed when compared to some of its competitors Tuesday, as Abbott Laboratories (ABT) fell 0.92% to $86.97, Becton Dickinson & Co. (BDX) fell 0.62% to $144.43, and Baxter International Inc. (BAX) rose 1.52% to $18.68.

Trading volume (700,420) remained 181,102 below its 50-day average volume of 881,522.

Data source: Dow Jones Market Data, FactSet. Data compiled June 2, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

06-02-26 1704ET

### Related Stocks

- [WST.US](https://longbridge.com/en/quote/WST.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [BDX.US](https://longbridge.com/en/quote/BDX.US.md)
- [BAX.US](https://longbridge.com/en/quote/BAX.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [A Look At West Pharmaceutical Services (WST) Valuation After Recent Share Price Consolidation](https://longbridge.com/en/news/288933254.md)
- [West Pharmaceutical Services' (WST) "Overweight" Rating Reiterated at Stephens](https://longbridge.com/en/news/288428697.md)
- [West Appoints Michel Lagarde to be President and Chief Executive Officer | WST Stock News](https://longbridge.com/en/news/288323873.md)
- ['Uzbekistan can offer incentives for Indian pharmas to boost investments'](https://longbridge.com/en/news/288949328.md)
- [Does Perceived Undervaluation at Baxter (BAX) Recast Its Margin Recovery and Portfolio Optimization Story?](https://longbridge.com/en/news/288966831.md)